Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Adaptimmune Therapeutics plc | 0 | 4,809,677 | +4,809,677 | 0 | 1,153 | 2.66% | +1,153 |
| Werewolf Therapeutics, Inc. | 4,309,860 | 4,309,860 | 0 | 4,189 | 4,698 | 10.84% | +509 |
| Repare Therapeutics, Inc. | 1,121,318 | 1,121,318 | 0 | 1,106 | 1,559 | 3.60% | +453 |
| Dyne Therapeutics, Inc.(DYN) | 682,376 | 682,376 | 0 | 7,138 | 6,496 | 14.99% | -641 |
| Adaptimmune Therapeutics plc | 5,335,715 | 0 | -5,335,715 | 1,051 | 0 | — | -1,051 |
| Entrada Therapeutics, Inc. | 4,381,062 | 4,381,062 | 0 | 39,605 | 29,441 | 67.92% | -10,164 |
| iTeos Therapeutics, Inc. | 2,738,785 | 0 | -2,738,785 | 16,351 | 0 | — | -16,351 |